This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...

Please provide your email address to receive an email when new articles are posted on . Patients with RA treated with first-line upadacitinib over 5 years had greater reductions in disease activity vs ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Split-dose methotrexate had greater efficacy and reduced the need for additional disease-modifying ...

Alembic Pharmaceuticals receives USFDA approval for a generic methotrexate injection used in treating cancer and arthritis.

Methotrexate significantly lowers systolic blood pressure in newly diagnosed RA patients compared to sulfasalazine, potentially reducing cardiovascular risk. The study provides prospective comparative ...

SAN DIEGO, CA—A post-hoc analysis of two trials found patients with active psoriatic arthritis treated with etanercept with or without methotrexate combination therapy had similar clinical and ...

Lymphoproliferative disorders (LPDs) represent a spectrum of conditions characterised by the uncontrolled proliferation of lymphoid cells. In patients with rheumatoid arthritis, the long‐term use of ...

The intracellular polyglutamation of methotrexate (MTX) is emerging as a crucial biochemical process in rheumatoid arthritis (RA) therapy. MTX polyglutamates (MTX-PGs) are metabolites formed by the ...

Alembic Pharmaceuticals' shares rose after receiving USFDA approval for its generic cancer treatment drug, Methotrexate ...

The medication methotrexate is used to treat cancer, arthritis, lupus and Crohn’s disease. Patients have reported trouble accessing it after the Supreme Court's ruling on abortion and a number of new ...

Alembic Pharmaceuticals secures USFDA approval for generic Methotrexate injection, boosting its oncology portfolio and strengthening its presence in the US generics market.